GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,217,000 | -3.5% | 143,420 | -0.4% | 0.94% | -3.6% |
| Q1 2022 | $6,442,000 | +0.3% | 144,050 | -1.0% | 0.97% | +7.9% |
| Q4 2021 | $6,420,000 | +8.8% | 145,568 | -5.8% | 0.90% | +12.4% |
| Q3 2021 | $5,903,000 | -6.4% | 154,499 | -2.4% | 0.80% | -3.1% |
| Q2 2021 | $6,304,000 | +5.9% | 158,313 | +0.2% | 0.83% | +6.0% |
| Q1 2021 | $5,952,000 | +1.8% | 157,927 | -0.6% | 0.78% | -12.2% |
| Q4 2020 | $5,845,000 | -6.7% | 158,839 | -4.6% | 0.89% | -19.3% |
| Q3 2020 | $6,267,000 | -11.3% | 166,503 | -3.9% | 1.10% | -14.8% |
| Q2 2020 | $7,068,000 | +6.6% | 173,283 | -0.9% | 1.29% | +1.5% |
| Q1 2020 | $6,628,000 | -20.0% | 174,940 | -0.7% | 1.27% | +11.8% |
| Q4 2019 | $8,280,000 | +7.7% | 176,200 | -2.2% | 1.14% | +13.0% |
| Q3 2019 | $7,690,000 | +4.3% | 180,169 | -2.2% | 1.01% | +3.7% |
| Q2 2019 | $7,372,000 | -4.1% | 184,199 | +0.1% | 0.97% | -8.7% |
| Q1 2019 | $7,687,000 | +10.1% | 183,953 | +0.6% | 1.06% | +4.8% |
| Q4 2018 | $6,984,000 | -21.0% | 182,777 | -17.0% | 1.01% | -9.8% |
| Q3 2018 | $8,843,000 | -0.9% | 220,149 | -0.6% | 1.12% | -5.4% |
| Q2 2018 | $8,926,000 | +6.2% | 221,428 | +2.9% | 1.19% | -0.9% |
| Q1 2018 | $8,406,000 | +29.0% | 215,161 | +17.1% | 1.20% | +20.9% |
| Q4 2017 | $6,515,000 | -10.3% | 183,676 | +2.7% | 0.99% | -14.8% |
| Q3 2017 | $7,263,000 | +2.4% | 178,883 | +8.7% | 1.16% | +2.7% |
| Q2 2017 | $7,093,000 | +5.3% | 164,503 | +3.0% | 1.13% | -1.6% |
| Q1 2017 | $6,733,000 | +16.7% | 159,691 | +6.6% | 1.15% | +10.1% |
| Q4 2016 | $5,768,000 | -14.6% | 149,765 | -4.4% | 1.05% | -12.0% |
| Q3 2016 | $6,756,000 | +2.8% | 156,633 | +3.3% | 1.19% | +9.2% |
| Q2 2016 | $6,572,000 | +13.2% | 151,641 | +5.9% | 1.09% | +5.9% |
| Q1 2016 | $5,806,000 | +3.6% | 143,185 | +3.1% | 1.03% | -3.4% |
| Q4 2015 | $5,603,000 | +7.1% | 138,869 | +2.0% | 1.06% | +10.9% |
| Q3 2015 | $5,233,000 | -1.8% | 136,089 | +6.3% | 0.96% | +3.1% |
| Q2 2015 | $5,330,000 | -7.3% | 127,969 | +2.7% | 0.93% | -8.2% |
| Q1 2015 | $5,752,000 | +16.7% | 124,631 | +8.1% | 1.01% | +7.3% |
| Q4 2014 | $4,930,000 | +1.1% | 115,343 | +8.8% | 0.94% | -5.9% |
| Q3 2014 | $4,875,000 | -3.0% | 106,039 | +12.8% | 1.00% | -5.2% |
| Q2 2014 | $5,028,000 | +7.5% | 94,019 | +7.4% | 1.06% | +3.4% |
| Q1 2014 | $4,677,000 | +2.6% | 87,538 | +2.5% | 1.02% | -2.6% |
| Q4 2013 | $4,560,000 | +9.4% | 85,417 | +2.8% | 1.05% | -8.1% |
| Q3 2013 | $4,167,000 | +1.5% | 83,063 | +1.1% | 1.14% | -7.6% |
| Q2 2013 | $4,106,000 | – | 82,170 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |